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Earlier studies carried out in our laboratory which 
demonstrated that disaggregated human epidermal cells 
isolated from normal flexor forearm skin produced a 
greater degree of primary allogeneic lymphocyte blas-
togenic response than did autologous peripheral blood 
mononuclear cells have since been confirmed by others. 
We have now completed a series of additional studies 
designed to determine the basis for this difference. 
Blocking studies with anti-HLA-DR antibodies revealed 
that the allogeneic response triggered by epidermal cells 
was completely dependent on the presence of unbound 
HLA-DR molecules eliminating the possibility that non-
specific mitogenic effects produced by the epidermal cell 
suspension might be responsible for the difference. In 
addition we were unable to demonstrate that epidermal 
keratinocytes were supplying a nonspecific helper or 
growth-promoting effect to the interaction between 
stimulating HLA-DR bearing Langerhans cells andre-
sponding T lymphocytes. Since it has recently been sug-
gested that the entire alloantigen-presenting capacity of 
unfractionated peripheral blood mononuclear cells can 
be attributed to a small population of HLA-DR antigen-
bearing dendritic cells, we have considered the possibil-
ity that the greater degree of allogeneic lymphocyte 
response produced by epidermal cells could be due to the 
presence of a greater percentage of HLA-DR positive 
dendritic cells present in epidermal cell suspensions (i.e., 
Langerhans cells). Peripheral blood dendritic cell-en-
riched fractions and epidermal cell suspensions that con-
tained similar percentages of dendritic cells produced 
equivalent amounts of allogeneic lymphocyte stimula-
tion, whereas peripheral blood dendritic cell-enriched 
fractions that contained greater percentages of den-
dritic cells than were present in epidermal cell suspen-
sions produced greater amounts of allogeneic stimula-
tion. We therefore conclude that the enhanced mixed 
lymphocyte reaction stimulating capacity of human ep-
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idermal cell suspensions could be explained by the fact 
that epidermal cell suspensions contain a greater per-
centage of HLA-DR bearing alloantigen-presenting den-
dritic cells than do unfractionated peripheral blood 
mononuclear cell suspensions. 
In an earlier study we presented data which demonstrated 
that epidermal cells isolated from flexor forearm skin of normal 
adult humans consistently produced greater degrees of alloge-
neic lymphocyte blastogenesis than did autologous peripheral 
blood mononuclear cells (PBMC) [1] . It has been assumed that 
the Ia (DR) antigen-bearing dendritic Langerhans cell (LC) is 
the epidermal cell type that functions as the stimulator cell in 
the primary allogeneic mixed epidermal cell-lymphocyte reac-
tion (MECLR) . However, LC comprise only about 4% of human 
epidermal cells. The vast majority of the remaining cells in this 
population are keratinocytes. Epidermal keratinocytes have 
recently been shown to be capable of secreting Interleukin-1 
(IL-1)-like [2-4] and thymopoietin -like [5] substances. In ad-
dition, keratinocytes can express Ia (DR) antigens in vivo under 
certain conditions (6- 7]. These observations would suggest the 
possibility that epidermal keratinocytes might also be involved 
in the MECLR, perhaps by augmenting the response initially 
triggered by LC. Another possible explanation for t he enhanced 
response seen in the MECLR might be that epidermal LC are 
inherently more efficient at alloantigen presentation than are 
those cells in the peripheral blood that serve as allogeneic 
stimulators in the mixed lymphocyte reaction. It might also be 
possible that LC represent a greater percentage of epidermal 
cell suspensions than do the alloantigen-presenting cell type 
present in PBMC suspensions. An examination of t hese pos-
sibilities has revealed that this final one could explain the 
MECLR- mixed lymphocyte reaction (MLR) differences that 
we have previously observed. 
MATERIALS AND METHODS 
Human Volunteers 
Healthy young adult male and female volunteers, consisting predom-
inantly of medical students and laboratory personnel, were paid to 
donate specimens of epidermis and venous blood simultaneously that 
was used to prepare the stimulator cell populations. Other unrelated 
healthy male and female volunteers were randomly selected and paid 
to donate venous blood that was used to prepare the responder PBMC. 
Reagents 
A murine monoclonal antibody (#203) specific for a nonpolymorphic 
determinant present on all HLA-DR molecules [8] was a generous gift 
from Dr. Peter Stastny. Indomethacin was purchased from Merck-
Sharp-Dohme. 
Isolation of Epidermal Cells 
Fresh epidermal cell suspensions were prepared from full -thickness 
epidermal biopsies taken from the flexor aspect of the forearm with a 
suction blister technique that has previously been described in detail 
(1]. Each blister top, consisting entirely of epidermis, was removed 
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with sterile iris scissors a nd forceps wi thout a nesthesia and washed in 
Hanks' balanced salt solut ion (HBSS). All five blister top epidermal 
sheets were then incubated in a 0.3% solut ion of hog pancreas t rypsin 
(1-250; ICN Nutritional Biochemicals, Clevela nd, Ohio) for 30 min at 
3TC and t hen were gently agitated at 5-min intervals over the next 30 
min to give a single ce ll suspension. After 3 washings in cold Ca+2 and 
Mg+2-free HBSS and a 5- min exposure at 23•c to 0.025% deoxyribo-
nuclease (Sigma, St. Louis, Missouri) to prevent mucoid reaggregation , 
t he epiderma l ce lls were fil te red t hrough ste rile 100-,.,m pore size nylon 
mesh (N itex HC3-100; T etco, Inc., Elmsford, New York) a nd then were 
resuspended in RPM! 1640 medium supplemented with 2 mM fresh L-
glu tamine, 15% heat-i nactivated pooled human AB serum, penicillin 
(400 U/ml), streptomycin (400 l'g/ml), and fungizone (1 ~tg/ml) 
(GIBCO, Grand Island, New York). Cell yield was t hen determined in 
a hemacytometer a nd t he cell suspension was exposed to 4000 rad 
gamma-irradiation from a 137Cesium source. Viability was t hen deter-
mined with a fluorescein diacetate ethidium bromide assay [9]. 
P rimary A llogeneic Mixed Epidermal Cell-Lymphocyte Cultures 
PBMC were prepared from venous blood by Isolymph (Gallard-
Schlesinger Chemical Co., Carle P lace, New York) density gradient 
centrifugation, washed 3X in HBSS a nd suspended in t he same com-
plete medium as described above. Mixed cultures of epidermal cells and 
PBMC were t hen set up in round-bottomed microtiter wells (Dynatech, 
Alexandr ia, Virginia ). T he cult ures consisting of 5 X 104 viable stimu-
lator epidermal cells and 1 x 10" responder PBMC in a fin al volume of 
0.2 ml were incubated for 144 h in a humidified 5% C02 atmosphere at 
37•c . E ighteen hours before harvesting, each culture was pulsed with 
1 ,.,Ci of tritiated thymid ine WHJTdR) (New Engla nd Nuclear, Boston, 
Massachusetts) . After washing, cells were collected wit h a MASH II 
automated cell harveste r onto glass fiber filters and t he amount of 
incorporated eHJTdR was determined by liquid scin ti llation spectros-
copy. All cultu res were carried out in t riplicate a nd t he results were 
expressed as mean counts per minute (CPM) ± 1 SD. Data were 
expressed as the D. CPM (CPM of cul tures contain ing both stimulator 
and responder cells minus the sum of t he CPM of t he stimulator and 
responder cell populations cul tured separately.) 
Primary Allogeneic Mixed Lymphocyte Cultures 
Mixed lymphocyte cult ures were set up in a manner simila r to that 
described fo r the mixed epidermal ce ll -lymphocyte cultures with the 
fo llowin g exception. The stimul ator cell population consisted of 
gamma-i rradiated PBMC t hat had been exposed to t he same trypsin 
and DNAase conditions t hat were necessary for epidermal cell isolation. 
Epidermal Kerotinocyte Culture Technique 
The technique of Liu and colleagues [10] was used to establish 
confluent pr imary cul tures of epidermal keratinocytes on collagen gels. 
Epidermal sheets derived from either suction blister biopsies of adult 
normal fl exor fo rearm skin or tryps in separated 0.3 mm-keratomed 
slices of normal adult t runkal skin were incubated in 0.3% trypsin in 
GNK solu tion (0.1% glucose, 0.15 M NaCl and 0.04% KCl) at pH 7.6 
in a 37•c water bath. The resulting epidermal cell suspension was 
passed t hrough a coarse mesh fil te r to remove debris. A 15 ml volume 
of Ca2+- a nd Mg'+- free HBSS was added a nd the cells were cen trifuged 
at 1800 rpm for 6 min. The supernatant was discarded and the cells 
were washed 2 addit ional t imes. The cell pellet was resuspended in 
Minimal Essential Medium with 10% fetal calf serum (FCS) containing 
ant ibiotics (penicillin 400 U/ml, streptomycin 400 ,.,g/ml and fungizone 
1 ,.,g/ml) and hydrocortisone (0.4 ,.,gjml) . After counting and viability 
determination t he cells were plated onto plastic dishes covered with a 
t hin layer of bovine collagen gel (Vit rogen-Collagen Corporation) at a 
concentration of 1.0- 1.5 X 105 viable cells/cm2 • The cells were t hen 
incubated at 3TC in a humidified 5% C02- 95% air atmosphere. At 18 
h and then approximately every 3 days thereafter the cells were fed 
with McCoy's 5A medium containing 10% FCS, antibiotics, and hydro-
cort isone at t he concent rations listed above. 
Peripheral Blood Dendritic Cell (PBDC) Enrichment Technique 
Pe ripheral blood dendritic cells (PBDC) were enriched by t he tech-
nique of Van Voorhis et al [11]. PBMC were isolated from 50 ml of 
whole heparinized blood using Ficoll 400/sodium diatrizoate (Histo-
paque 1.077, Sigma Chem ical Co.). The PBMC's were suspended in 
RPMI 1640 containing 5% FCS, antibiotics (100 U/ml penicillin, 100 
U/ml streptomycin, and 50 ,.,gj ml gentamicin), 1 mM L-glutamine, and 
5 X 10- 5 M 2- mercaptoethanol. The cells were then plated onto a 100-
mm plastic cul ture plate for 1 h at 37•c fo llowi ng which the non -
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adherent cells were removed and discarded. Fresh media was added to 
the adherent cells, after which they were reincubated for 16 h at 37•c. 
The cells that were not attached after this overnight incubation were 
collected, plated in fresh medium onto a nother 100 mm plate and 
incubated for 1 additional h at 37·c. The · cells that had remained 
attached afte r overnight incubation were collected with a rubber po-
liceman and used as t he "adherent macrophage" population. The cells 
that had not attached for the second time (the "released 2x" popula -
t ion) were resuspended in 4 ml of bovine serum albumin (BSA) (d = 
1.082) and carefully overlayed with 2 ml of BSA (d = 1.047). The tube 
was cent rifuged for 10,000 g for 10 min at 4 · c. The interface cell layer 
(the "low density released 2X" population) was removed a nd washed 
3X in RPM! 1640. This layer contained approximately 10- 30% den-
dritic cells. The cells at the bottom of the tube were collected, washed 
3X in RPMI 1640 a nd used as the "high density released 2x" popula-
tion. 
To examine the cells by phase cont rast microscopy, 2 X 105 cells 
were centrifuged onto 15-mm circular coverslips (which had been 
precoated wit h 75 ~tg/ml poly-L-lysine) for 10 min at 400 g. The cells 
were incubated for at least 20 min in RPM! 1640 at 3TC to allow 
spreading of t he dendritic cells. Prior to examination the cells were 
fixed in 1.25% glutaraldehyde in phosphate buffered saline for 15-30 
mm. 
RESULTS 
The Allogeneic Lymphocyte Response Induced by Epidermal 
Cells Requires Expression of Unbound HLA -DR Molecules 
Fig 1 shows the results of a study which examined t he 
blocking effect of a monoclonal HLA-DR antibody on t he 
MECLR and MLR response. As can be seen both responses 
were blocked in a similar dose-dependent fashion across a broad 
range of ant ibody concent rations. At a 1:10 antibody dilution 
both the MECLR and MLR response was inhibited by approx-
imately 80%. Both responses were still significantly depressed 
at 1:160 ant ibody concentration. No blocking effect was pro-
duced by an irrelevant monoclonal antibody (anti -arsenate) in 
a similar study (data not shown). 
The kinetics of this HLA-DR antibody blocking effect were 
examined in an experiment shown in Fig 2. The maximum 
blocking effect was seen when the antibody was added at t he 
time of culture init iation. Addition of the antibody after 48 h 
of culture did not produce significant blocking of the MECLR 
or MLR response. The failure of the antibody to block either 
response when added after 48 h argues against the possibility 
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FJG 1. Effect of ant i-HLA-DR antibody on primary allogeneic 
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cultures. The amount of [3H]TdR incorporation was determined after 
6 days (144 h) in culture. Note that the [3H]TdR incorporation on t he 
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FIG 2. Kinetics of anti-HLA-DR antibody blocking effect on 
MECLR and MLR responses. A 1:10 dilution of anti-HLA-DR antibody 
was added to MECLR and MLR cultures at the time of culture 
initiation or at various time intervals thereafter. Equal volumes of fresh 
media were added to control MECLR and MLR cultures at the same 
timepoints. The cultures were harvested and [3H]TdR incorporation 
assayed at 144 h. 
that the blocking effect seen when antibody was added at earlier 
time points was the trivial result of nonspecific toxic effects of 
the antibody preparation. It is likely that the HLA-DR antibody 
blocking effect results from binding of the antibody to the DR 
antigens present on the stimulating cells (i.e., Langerhans 
cells). In support of this are the findings of Hefton et a! (12] 
who showed that pretreatment of human epidermal cell suspen-
sions with anti-HLA-DR antibody and complement completely 
abrogated the MECLR response. It is likely that the activated 
responder T cells in a MECLR reaction also become HLA-DR 
positive since helper T cells activated in different ways have 
been shown to express these antigens. The kinetics of the 
MECLR blocking effect suggest that the DR antibody blocking 
effect is not due to reaction with DR antigens on activated T 
cells. If this were the case then one would expect that addition 
of the antibody near the end of the cu lture period would be as 
effective in blocking the response. Our studies showed however 
that addition of the antibody after 48 h in culture resulted in 
no significant blocking. 
T he results of these 2 experiments strongly suggest that, as 
has been shown previously for the MLR, the MECLR response 
is very much dependent on the expression by a viable stimulat-
ing cell population of cell surface HLA-DR molecules. These 
results also argue against the remote possibility that the en-
hanced allogeneic lymphocyte stimulating capacity of epider-
mal cells that we had observed was due to nonspecific mitogenic 
effects produced by something in the epidermal cell suspension. 
Keratinocytes Present in Epidermal Cell Suspensions Are not 
Responsible for the Enhanced MECLR Response 
We have taken several approaches to examining the possi-
bility that keratinocytes present in the epidermal cell suspen-
sions might be supplying some growth promoting effect (e.g., 
IL-l) that could be producing the enhanced MECLR response. 
Fig 3 shows the results of an experiment which examined the 
effects on the MLR response produced by the addition of 
culture supernatants from stimulator epidermal cells or PBMC 
cultured a lone. The addition of epidermal cell culture super-
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FIG 3. Effect of epidermal cell culture supernatants on the MLR 
response. 106-irradiated epidermal cells in suspension were cultured 
alone in microtiter wells under the same culture conditions previously 
described for MECLR cultures. At the end of 6 days the supernatant 
from the epidermal cell culture was collected and added to fresh MLR 
cultures at a 25% (v/v) concentration. As controls, MLR cultures were 
carried out in the presence of 6-day culture supernatants from PBMC 
or cultured alone in the absence of any added culture supernatant. 
natants did not augment the MLR response above that seen 
with standard MLR cultures or MLR cultures containing 
PBMC culture supernatants. Similar results were seen with 
MLR cultures carried out in the presence of 50% epidermal cell 
culture supernatants (data not shown). 
The effect on the MLR response produced by the addition of 
epidermal cells that were autologous to the responding PBMC 
cell population is shown in Fig 4. The addition of epidermal 
cells isolated from the same individual whose PBMC were being 
used as responder cells did not augment the MLR response. In 
fact the MLR response was somewhat suppressed by t he addi-
tion of such responder-derived epidermal cells. However, this 
probably resulted from competition for nutrients in the culture 
medium in view of the fact that these cultures contained 5 x 
104 more viable cells than did the standard MLR cultures since 
the same effect was seen on the MECLR cultures. 
Our final attempt to demonstrate a MLR-augmenting effect 
by keratinocyte-derived products is shown in Fig 5. No MLR 
response enhancing effect was seen with the addition of kera-
tinocyte culture supernatants taken at any time point. In fact 
in both experiments the supernatants collected on and after 
day 3 appeared to significantly suppress the MLR response. 
These studies taken together virtually eliminate the possi-
bility that products produced by the keratinocytes in our 
MECLR culture system are responsible for augmenting the 
allogeneic lymphocyte stimulating response. 
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concentration (v/v) to MLR cultures at the time of culture initiation. 
In this system confluent keratinocyte growth is usually seen between 
days 5 and 7. 
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Comparison of Epidermal Cell and Peripheral Blood Dendritic 
Cell (PBDC) Allogeneic Lymphocyte-Stimulating Capacities 
We attempted to enrich for PBDC by the diffe rentia l adher-
ence technique described by Van Voorhis and coworkers [11] . 
We were successful in producing cell fractions t hat contained 
small percentages of cells which assumed a unipola r or bipolar 
dendritic appearance on poly-L-lysine (see Fig 6). However our 
reproduction of this technique yielded lower percentages of 
dendritic cells than those reported by Van Voorhis et a l (see 
Table 1) . 
Fig 7 shows t he results of 5 separate experiments in which 
the MLR stimulating capacity of PBMC was compa red to that 
of autologous firmly adherent macrophages and cell fractions 
containing different percentages of autologous PBDC. The 
firmly adherent macrophages elicited virtually no MLR re-
sponse, whereas those cell fractions which were enriched for 
PBDC produced greater responses t han did unfractionated 
PBMC. The cell fraction which conta ined the greatest percent-
age of PBDC (the "low dens ity released 2X" population) elicited 
a response that was 3-fold greater t han that produced by 
unfractionated PBMC. These results are in agreement with t he 
findings of Van Voorhis et al and others [11,13-14]. 
Fig 8 shows the result of 3 separate experimen ts in which 
the MLR stimulating capacities of epidermal cells and autolo-
gous PBDC-enriched fractions were compared. As previously 
demonstrated unfractionated PBMC produced a lower response 
t han that of epidermal cells . The PBDC-enriched fraction 
which contained a percentage of dendritic cells t hat was roughly 
FIG 6. Phase cont rast microscopic appearance of peripheral blood 
dendritic cells on a poly-L-lysine-coated coverslip. Note the unipolar 
dendritic morphology (closed arrowheads). A fried egg-shaped, ruffled-
edged macrophage can be seen in the upper right-hand corner (open 
arrowhead). Original magnification X 630. 
TABLE I. Yields of peripheral blood dendritic cell enrichment 
procedures 
Cell fraction 
Released 2X 
Low density 
Released 2X 
High density 
Released 2X 
% Dendritic cells 
Van Voorhis et allll] 
3-6% 
10-30% 
1- 4% 
Our tech nique 
1-5% 
8- 15% 
0- 4% 
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equivalent to the percentage of epidermal LC present in our 
epidermal cell suspensions (the " released 2X" fract ion) pro-
duced an MLR response that was similar to the response 
elicited by epidermal cells. The PBDC-enriched fraction which 
contai ned a higher percen tage of dendritic cells t han were 
present in ep idermal cell suspensions (the "low density released 
2X" population) produced a significant ly higher MLR response. 
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of init iation of MLR cultures. 
Effect of Indomethac£n on MLR 
It is possible that a radioresistant suppressor cell is lost 
during the PBDC enrichment procedure. The loss of such a cell 
might resul t in a higher MLR response. Since one form of 
suppression is prostaglandin mediated, we have examined t he 
effect on t he MLR of blocking prostaglandin production. Fig 9 
shows the effect that a wide range of indomethacin concentra-
tions had on a MLR response. None of t he indomethacin 
concentrations studied augmented the response, as would be 
predicted if a prostaglandin-mediated suppressor mechanism 
was responsible fo r down regulating the MLR response. Thus 
it seems unlikely that the high MLR response induced by 
PBDC-enriched fractions was due to loss of a prostaglandin-
mediated suppressor cell function. 
DISCUSSION 
A number of earlier studies have documented t hat human 
epidermal cells can substitute for lymphoid cells as stimulators 
in the primary allogeneic MLR (15-18]. These studies have 
found for t he most part that the response produced by epider-
mal cells was equal to or less than that produced by autologous 
PBMC. Our more recent studies, however, have clearly dem-
onstrated that freshly prepared flexor forearm epidermal cells 
are considerably more efficient alloant igen -presenting cells, on 
a cell for cell basis, t han are PBMC [1] . This observation has 
now been confirmed by other investigators [19]. It is likely that 
differences between the various techniques used in these studies 
to obtain epidermal cell suspension might account for the 
discrepancy between our finding and those of the earlier inves-
tigators . 
The current series of studies were carried out to determine 
the basis for the enhanced alloantigen-presenting capacity pos-
sessed by epidermal cell suspensions. Even though epidermal 
kerati nocytes are capable of secreting immunologically active 
cytokines and expressing HLA-D region products, our studies 
suggest t hat these qualities do not confer upon this cell type 
the capacity to augment the primary T-cell response to a lloan-
t igens. Our studies however have not excluded t he possibility 
that the T -cell response is being augmented by organ specific 
alloant igens that might be present on epidermal ce lls. The 
presence of such antigens has never been documented on hu-
man epidermal cells; however, t here is some data which suggest 
their presence on murine epidermal cells [20,21]. We have 
begun to examine this possibility by looking for MECLR reac-
tivity between HLA identical siblings. We have found no sig-
nificant MECLR reactivity between 2 separate HLA identical 
sibling pairs. A third sibling pair did demonstrate MECLR 
reactivity, however a question was raised as to t heir true HLA 
identity by the fact t hat t hey were also MLR reactive (unpub-
26s SONTHEIMER 
Ii shed personal observations) . Pittelkow and Steinmueller [19] 
have found no sign ificant primary a llogeneic MECLR reactivity 
between a larger number of HLA identical s ibling pairs. There-
fore, it seems unlikely t hat epidermal cell-specific a lloantigens 
are responsible for the augmented MECLR response t hat we 
have observed. 
The demonstration by Van Voorhis et a l [11] that PBMC 
contain a small percentage (0.1 %-0.5%) of dendrit ic cells which 
can be enriched by differential adherence a nd density separa-
tion techniques, has a llowed us to direct ly compare the a lloan-
tigen-presenting capacities of t he dendritic cell populations 
present is epidermis and venous b lood. These studies have 
revealed that the alloantigen-presenting capacities of these 2 
populations of dendritic cells are very similar a nd have con-
firmed Van Voorhis et al's observation s which suggest t hat the 
dendritic cells present in peripheral blood is a very potent 
alloantigen-presenting cell type. This functional similarity be-
tween epidermal LC and PBDC raises the possibility that t he 
PBDC might be the circulat ing precursor of t he epidermal LC. 
Human PBDC and LC differ in t hat PBDC lack certain mem-
brane con stituen ts and cytoplasmic organelles possessed by LC 
(OKT-6 antigen, Fe receptors and Birbeck granules) [11]. Per-
haps these characteristics are acquired by t he PBDC as this 
cell differentiates and matures on its way to, or while in , its 
final resting place in the suprabasalar layer of t he epidermis. 
I would like to express my gratitude to Irene Dougherty for her 
expert technical assistance and Kim Green for her help in preparing 
the manuscript. 
This work is dedicated to the memory of Dr. James N. Gilliam who 
died while the manuscript was being prepared. His advice concerning 
the design, execution, and interpretation of the results of these studies 
was vital to the completion of t his project. His support, guidance, and 
fr iendship will be greatly missed. 
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